Skip to main content
Premium Trial:

Request an Annual Quote

Strand Genomics Pockets $4.6M in First VC Financing Round

NEW YORK, Sept. 19 - Strand Genomics today said it has secured $4.6 million in its first private-equity financing round.


WestBridge Capital Partners, based in San Francisco, led the round, which included an investment by UVI Venture Funds and angel investors, Strand said.


Strand Genomics will use the money to "expand" its presence in Europe and develop a platform to analyze ADME and associated toxicology properties of molecules, among other things, according to Sreeni Devidas, the firm's vice president of business development and strategy.


Click here for more information.

The Scan

mRNA-Based Vaccine on the Way in China

China may soon have its own mRNA-based vaccine, according to Nature News.

Arranged Killing, Fraud Alleged by Prosecutors

The Wall Street Journal reports that prosecutors allege that the co-founder of a biotech arranged to have a business associate who threatened to expose him as a fraud killed.

Whirlwind Decade of CRISPR

The New York Times looks back at the 10 years since the University of California, Berkeley's Jennifer Doudna and her colleagues published their CRISPR paper.

PNAS Papers on Blue Cone Monochromacy Structural Variants, HIV-1 Mutant, T-ALL

In PNAS this week: structural variants linked to blue cone monochromacy, HIV-1 variants affecting the matrix protein p17, and more.